In already diagnosed individuals, there were significant differences in sex, diabetes duration, eGFR, PCS score, the number of people with retinopathy and the number of people using glucagon-like peptide-1 receptor agonists (GLP1-RAs), insulin and other glucose-lowering drugs. Here, GLP1R is linked to retinal disorder.